Beyond Inhibition: Rebalancing the Hsp90 Chaperone Network as a Therapeutic Strategy for Alzheimer’s Disease
Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-15
DOI: 10.2147/dddt.s602287 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Zhikang Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Alzheimer Disease, Molecular Chaperones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
- Department of Anesthesiology, Ganzhou Key Laboratory of Anesthesiology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
ORCID-Profile: Weidong Liang, Shihong Li
Zitieren
APA
Tang, Z., Xie, H., Xu, Y., Zhou, Z., Lu, F., Wu, Q., Liang, W., Zhong, M., & Li, S. (2026). Beyond Inhibition: Rebalancing the Hsp90 Chaperone Network as a Therapeutic Strategy for Alzheimer’s Disease. Drug Design, Development and Therapy, Volume 20, 1-15. https://doi.org/10.2147/dddt.s602287
Vancouver
Tang Z, Xie H, Xu Y, Zhou Z, Lu F, Wu Q, et al. Beyond Inhibition: Rebalancing the Hsp90 Chaperone Network as a Therapeutic Strategy for Alzheimer’s Disease. Drug Design, Development and Therapy. 2026;Volume 20:1-15. doi:10.2147/dddt.s602287
BibTeX
@article{Tang2026,
author = {Tang, Zhikang and Xie, Haiyu and Xu, Yongxing and Zhou, Zhenhong and Lu, Feng and Wu, Qiaozhen and Liang, Weidong and Zhong, Maolin and Li, Shihong},
title = {Beyond Inhibition: Rebalancing the Hsp90 Chaperone Network as a Therapeutic Strategy for Alzheimer’s Disease},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--15},
doi = {10.2147/dddt.s602287}
}
EUVIMED